ArticleRheumatology advances in practice2025

Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysis.

Dafna D Gladman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.